Inga-Maria Pauliina Launonen

Peter K. Sorger

• Harvard University
• Harvard Med Sch, Harvard University, Harvard Medical School, Harvard Ludwig Ctr, Lab Syst Pharmacol
• Harvard Medical School
• Harvard University

Extern person

Kevin M. Elias

• Brigham & Womens Hosp, Harvard University
• Harvard Med Sch, Harvard University, Brigham & Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Brigham & Womens Hosp, Ctr Sarcoma & Bone Oncol, Dana Farber Canc Inst,Div Surg Oncol
• Harvard University

Extern person

Panagiotis A. Konstantinopoulos

• Harvard Med Sch, Harvard University, Dana-Farber Cancer Institute, Harvard Medical School, Dana Farber Canc Inst, Ctr DNA Damage & Repair
• Dana Farber Canc Inst, Dana-Farber Cancer Institute, VA Boston Healthcare System, Harvard University, ALL Consortium
• Harvard Med Sch, Harvard University, Dana-Farber Cancer Institute, Harvard Medical School, Dana Farber Canc Inst, Dept Radiat Oncol
• Harvard Med Sch, Harvard University, Brigham & Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Brigham & Womens Hosp, Ctr Sarcoma & Bone Oncol, Dana Farber Canc Inst,Div Surg Oncol
• Harvard Univ, Harvard University, Harvard Business Sch
• Dana-Farber Cancer Institute

Extern person

Alan D. D'Andrea

• Dana Farber Canc Inst, Dana-Farber Cancer Institute, VA Boston Healthcare System, Harvard University, ALL Consortium
• Harvard Med Sch, Harvard University, Dana-Farber Cancer Institute, Harvard Medical School, Dana Farber Canc Inst, Ctr DNA Damage & Repair
• Harvard Med Sch, Harvard University, Dana-Farber Cancer Institute, Harvard Medical School, Dana Farber Canc Inst, Dept Radiat Oncol
• Harvard Med Sch, Harvard University, Brigham & Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Brigham & Womens Hosp, Ctr Sarcoma & Bone Oncol, Dana Farber Canc Inst,Div Surg Oncol
• Dana-Farber Cancer Institute

Extern person

J. R. Lin

• Harvard Med Sch, Harvard University, Harvard Medical School, Harvard Ludwig Ctr, Lab Syst Pharmacol

Extern person

N. Lyytikäinen

• Univ Helsinki, University of Helsinki, Fac Med, Res Programs Unit, Res Program Syst Oncol

Extern person

K. C. Strickland

Extern person

Zoltan Maliga

• Harvard University
• Harvard Med Sch, Harvard University, Harvard Medical School, Harvard Ludwig Ctr, Lab Syst Pharmacol

Extern person

Connor A. Jacobson

• Harvard University
• Harvard Med Sch, Harvard University, Harvard Medical School, Harvard Ludwig Ctr, Lab Syst Pharmacol

Extern person

Sandro Santagata

• Harvard University
• Brigham & Womens Hosp, Harvard University, Brigham & Women's Hospital, Lab Syst Pharmacol

Extern person

E. A. Anttila

Extern person

A Szabo

• Comenius Univ, Comenius University Bratislava
• Univ Helsinki, University of Helsinki, Fac Med, Res Programs Unit, Res Program Syst Oncol

Extern person

B. E. Howitt

• Stanford University

Extern person

Hye-Jung Kim

• Harvard Univ, Harvard University, Harvard Business Sch

Extern person

Johanna Hynninen

• Department of Obstetrics and Gynaecology, University of Turku and Turku University Hospital
• Univ Turku, University of Turku, Turku BioImaging
• University of Turku
• Univ Turku, University of Turku, Clin Neurosci, Dept Neurosurg, Turku Brain Injury Ctr,Turku Univ Hosp
• University of Turku

Extern person

Michael J. Kearns

• Harvard Univ, Harvard University, Harvard Business Sch

Extern person

Ajit J. Nirmal

• Harvard Medical School

Extern person

Foteini Chamchougia

• Heart and Lung Centre HUCH and Helsinki University

Extern person

Thomas M. Roberts

• Harvard Univ, Harvard University, Harvard Business Sch

Extern person

Tao Jiang

• Key Laboratory of Biomedical Polymers of Ministry of Education,Department of Chemistry, Wuhan Univeristy
• University of Cambridge
• Harvard Univ, Harvard University, Harvard Business Sch

Extern person

Changli Qian

• Harvard Univ, Harvard University, Harvard Business Sch

Extern person

Qiwei Wang

• Harvard Univ, Harvard University, Harvard Business Sch

Extern person

Joyce F. Liu

• Harvard Med Sch, Harvard University, Dana-Farber Cancer Institute, Harvard Medical School, Dana Farber Canc Inst, Dept Radiat Oncol
• Harvard Univ, Harvard University, Harvard Business Sch
• Dana-Farber Cancer Institute

Extern person

Shaozhen Xie

• Harvard Univ, Harvard University, Harvard Business Sch

Extern person

Ursula A. Matulonis

• Dana Farber Canc Inst, Dana-Farber Cancer Institute, VA Boston Healthcare System, Harvard University, Canc Risk & Prevent Clin
• Harvard University
• Dana Farber Canc Inst, Dana-Farber Cancer Institute, VA Boston Healthcare System, Harvard University, ALL Consortium
• Harvard Med Sch, Harvard University, Dana-Farber Cancer Institute, Harvard Medical School, Dana Farber Canc Inst, Dept Radiat Oncol
• Harvard Univ, Harvard University, Harvard Business Sch
• Dana-Farber Cancer Institute

Extern person

Jean J. Zhao

• Harvard Univ, Harvard University, Harvard Business Sch

Extern person

Xin Cheng

• Harvard Univ, Harvard University, Harvard Business Sch

Extern person

Tuulia Vallius

• Turku University Hospital
• Harvard Medical School
• Harvard University

Extern person

Ziying Lin

• Harvard Univ, Harvard University, Harvard Business Sch
• Sun Yat Sen Univ, Sun Yat Sen University, Sun Yat Sen Mem Hosp, Dept Spine Surg

Extern person

Gordon J. Freeman

• Harvard Univ, Harvard University, Harvard Business Sch

Extern person

Antons Martincuks

• City Hope Natl Med Ctr, Beckman Research Institute of City of Hope, City of Hope, Beckman Res Inst

Extern person

Liya Ding

• Harvard Univ, Harvard University, Harvard Business Sch

Extern person

Yau-Hua Yu

• Harvard Univ, Harvard University, Harvard T.H. Chan School of Public Health, Sch Publ Hlth, Dept Oral Med Infect & Immun
• City Hope Natl Med Ctr, Beckman Research Institute of City of Hope, City of Hope, Beckman Res Inst

Extern person

Ella Anttila

Extern person